Topic
24 articles
A long-standing bureaucratic obstacle to privately-funded medical marijuana research has just been removed, effective immediately. The Department of Health and Human Services determined that the PHS review process is redundant with the FDA review, and that...
During its 2014 session, the Alabama Legislature passed a law authorizing a state-sponsored study of the efficacy of CBD in treating seizure disorders. Advocates of medicinal cannabis in Alabama were encouraged by the passage of Carly's Law, but their enthusiasm quickly waned when it became apparent that federal government bureaucracy would be a roadblock to the study's progress.
The weed you purchase legally at a government sanctioned dispensary is still just as variable as the strains you might buy from a dealer.
The administration of nabilone, a synthetic cannabinoid, safely mitigates symptoms of post-traumatic stress (PTS) syndrome, according to clinical data published online ahead of print in the Journal of Psychopharmacology.
The FDA is conducting an analysis at the Drug Enforcement Administration’s request on whether the U.S. should downgrade the classification of marijuana as a Schedule 1 drug.
British drug maker GW Pharmaceuticals released the first results on the efficacy and safety of Epidiolex, with an average reduction in seizure frequency of 50% among a group of 27 children and young adults with treatment-resistant epilepsy.
Newly discovered documents from tobacco company archives a t UC San Francisco show that major companies in the cigarette industry investigated joining the marijuana business in the late 1960s and early 1970s.
Earlier this year, Kentucky law makers passed a bill that would allow for the first legally approved medicinal use of cannabis in the state. Elation soon turned to heartbreak with the news that
Commonly referred to as "heroin in a bottle," Zohyrdo ER has received staunch opposition from local and national lawmakers who are afraid that this pill will wreak havoc on our society.
Issues are the availability of marijuana oil, approval from the FDA and the cost of studies that preliminary estimates say could be $10,000 per participant.
Patients who use medical marijuana for pain and other chronic symptoms can take an unwanted hit: Health Insurers don't cover the treatment
Lawmakers approved legislation authorizing the physician-supervised use of varieties of cannabis high in the non-psychotropic cannabinoid cannabidiol (CBD).
While the passage of these measures may pose symbolic victories for legislators; they fail to provide tangible benefits to the constituents that they serve.
The Obama administration handed backers of medical marijuana a significant victory last Friday, opening the way for a University of Arizona researcher...
Americans for Safe Access (ASA) will host a Google Hangout today, March 12th at 8pm EDT, featuring AHP director Roy Upton, ASA scientific advisory board member Dr. Sunil Aggarwal and others.
Thousands of veterans and other medical marijuana patients nationwide use marijuana to treat symptoms of post-traumatic stress disorder (PTSD)...
Here's the latest major medical marijuana news around the United States from the past week, as of February 26, 2014.
Here's the top 10 items from NORML that shaped cannabis policy in 2013, from no association between lung cancer and smoking weed to Uruguay legalizing...
